SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Illumina (ILMN) Optics for Genomics
ILMN 119.97-2.9%Nov 3 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (132)10/25/2005 4:45:48 PM
From: mopgcw   of 276
 
Illumina Challenges Ownership Rights for Patent Covering ParAllele Technology Acquired by Affymetrix
Monday October 24, 9:00 pm ET

SAN DIEGO--(BUSINESS WIRE)--Oct. 24, 2005--Illumina, Inc. (NASDAQ: ILMN - News) announced today that it has made a formal filing with the United States Patent and Trademark Office (USPTO) requesting Interference with U.S. Patent Number 6,858,412. The '412 patent relates to the molecular inversion probe genotyping technology of ParAllele BioScience, which was recently acquired by Affymetrix.
ADVERTISEMENT


An Interference is a proceeding instituted in the USPTO for determining priority of invention between two parties claiming the same invention. The party identified as the first to invent is ultimately awarded ownership and entitlement to the invention under U.S. patent law. The invention at issue, although not currently in use at Illumina, was invented by Illumina scientists during the course of early research and development at the company. Illumina's request for interference is based on an Illumina patent application describing the invention and filed prior to the '412 Patent. The earlier filing date is expected to establish Illumina as the "senior party" in the Interference proceeding, placing on the '412 patent inventors the burden of proof to establish an earlier date of invention.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News